Cite

    Xu, R. et al. (2021). Developing a physiologically based pharmacokinetic model of apixaban to predict scenarios of drug–drug interactions, renal impairment and paediatric populations. British journal of clinical pharmacology. 87 (8), pp. 3244-3254. [Online].